Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Roche Raises Illumina Bid to $51, Seeking Faster Deal
March 30, 2012
Illumina, the U.S. maker of gene-mapping tools, rose above Roche’s increased hostile takeover bid, indicating investors are betting that an even higher offer will come.
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing